The tumor development and metastasis are closely related to the structure and function of
the tumor microenvironment (TME). Recently, TME modulation strategies have attracted …

Immunotherapy that harnesses the human immune system to fight cancer has received
widespread attention and become a mainstream strategy for cancer treatment. Cancer …

Despite rapid advancements in the field of nanotechnology, there is mounting frustration in
the scientific community regarding the translational impact of nanomedicine. Modest …

With the development of nanotechnology, significant progress has been made in the design,
and manufacture of nanoparticles (NPs) for use in clinical treatments. Recent increases in …

Passive targeting is the foremost mechanism by which nanocarriers and drug-bearing
macromolecules deliver their payload selectively to solid tumors. An important driver of …

Background Cancer is one of the major causes of death and is difficult to cure using existing
clinical therapies. Clinical cancer treatments [such as surgery, chemotherapy (CHT) …

Breast cancer is the most common malignant disease in women worldwide, but the current
drug therapy is far from optimal as indicated by the high death rate of breast cancer patients …

Recent developments in nanotechnology have brought new approaches to cancer
diagnosis and therapy. While enhanced permeability and retention effect promotes nano …

Advanced research has revealed the crucial role of tumor microenvironment (TME) in
tumorigenesis. TME consists of a complicated network with a variety of cell types including …

During the last decade, peptide‐based nanomaterials are recognized as upcoming
biomedical materials for tumor imaging and therapy. The rapid expansion of peptides and …